HOME › DRUGS › SODIUM PHENYLBUTYRATE;URSODOXICOLTAURINE
ACTIVE SUBSTANCE / INN

SODIUM PHENYLBUTYRATE;URSODOXICOLTAURINE

Brand name(s): Albrioza
EMA LISTED
REFUSED
Amyotrophic Lateral Sclerosis
ACTIVE SUBSTANCE
Sodium Phenylbutyrate;Ursodoxicoltaurine
REGULATORS
EMA
SPONSORS / MAH
Amylyx Pharmaceuticals EMEA B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AlbriozaAmylyx Pharmaceuticals EMEA B.V.RefusedAmyotrophic Lateral Sclerosis

FULL INTELLIGENCE ON SODIUM PHENYLBUTYRATE;URSODOXICOLTAURINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →